Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F. Farhat
Pcn197 - Cost Utility Analysis of First-Line Paclitaxel With Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab Versus Pemetrexed With Carboplatin Followed by Maintenance Pemetrexed in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer in Lebanon
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Randomized Phase II Trial of Paclitaxel and Carboplatin Followed by Gemcitabine Switch-Maintenance Therapy Versus Gemcitabine and Carboplatin Followed by Gemcitabine Continuation-Maintenance Therapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
P3.01-94 Safety and Efficacy of First-Line Pemetrexed Versus Bevacizumab-Containing Regimens in Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients
Molecular and Clinical Oncology
Cancer Research
Oncology
Induction of Peripheral Effector CD8 T Cell Proliferation by Combination of Paclitaxel, Carboplatin and Bevacizumab in Non-Small Cell Lung Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
P1.01-87 a Phase 1b Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Patients With Stage 4 Non-Squamous Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Analysis of Continuous First‑line Treatment With Docetaxel and Carboplatin for Advanced Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Sex Differences in Outcome With Bevacizumab Therapy: Analysis of Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With or Without Bevacizumab in Combination With Paclitaxel and Carboplatin in the Eastern Cooperative Oncology Group Trial 4599
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Squamous Non–Small-Cell Lung Cancer: Results From the Randomized Controlled MONET1 Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
